GO
Loading...

Medicine

More

  • A Rise For Biopharma In The Fall? Wednesday, 16 Sep 2009 | 12:14 PM ET

    Today is the 16th annual "Newsmakers in Biotech" event put on by Thomson Reuters and BioCentury.

  • Auxilium, Pfizer Could Get A Helping Hand Tuesday, 15 Sep 2009 | 4:51 PM ET

    Tomorrow I'll be hanging out at the BioCentury/Thomson Reuters "Newsmakers in the Biotech Industry" conference in NYC, so I won't be able to monitor the webcast of an FDA panel meeting for a most intriguing drug.

  • A Ghost Of A Chance In Pancreatic Cancer Tuesday, 15 Sep 2009 | 12:24 PM ET
    Patrick Swayze

    Patrick Swayze is sadly a statistic. He is one of an estimated 35,000 people in the United States who will die from pancreatic cancer this year. Several companies are working on drugs for the disease, but the path is littered with failures.

  • Will Pot TV Show Bring 'High' Ratings? Tuesday, 15 Sep 2009 | 10:26 AM ET
    Marijuana

    Tips for cultivating marijuana. Testimonials by patients about its medical benefits. Cannabis cooking lessons. Even citations for award-winning strains of pot. Viewers here can now watch, every week, what amounts to a pro-weed news program.

  • Lilly: 'Let's Get Small'-er Monday, 14 Sep 2009 | 1:41 PM ET

    Surely, Eli Lilly didn't throw it's restructuring plan together in a couple of weeks, but it was just the end of last month when Leerink Swann analyst Seamus Fernandez said LLY needed to cut costs and/or do a big deal. So, kudos to him for getting out ahead of it.

  • Mylan Parts Ways With PR Tradition Thursday, 10 Sep 2009 | 9:53 AM ET
    Mylan Laboratories Inc. headquarters

    Usually when a company announces an executive departure the news comes out in a press release with a header along the lines of , "So-and-so to retire, search begins for successor," or, "XYZ Corp. CEO resigns, interim CEO appointed," etc.

  • The Qnexa Question Wednesday, 9 Sep 2009 | 5:22 PM ET
    Qnexa

    Some analysts had been telling clients recently that they thought Vivus' diet drug Qnexa could take the lead in the three-contestant race to get the next prescription diet pill on the market. But they didn't think it would take such a commanding lead.

  • The Roche Management Merry-Go-Round Tuesday, 8 Sep 2009 | 9:40 AM ET

    Talk about a short tenure. Only eight months after Roche installed him as CEO of Genentech, Pascal Soriot is moving on (up?) to become COO of Roche's Pharma Division.

  • Pfizer's Big News. Or Is It? Wednesday, 2 Sep 2009 | 2:17 PM ET

    Lost in the coverage of the Pfizer-Wyeth deal that day, but nonetheless disclosed in the company's simultaneous earnings release back on January 26th of this year, PFE revealed it had taken a $2.3 billion charge for a pending settlement over marketing.

  • Cancer Drugs Mean Big Profits, Big Risks for Big Pharma Wednesday, 2 Sep 2009 | 1:51 PM ET
    Big Pharma

    Virtually every large pharmaceutical company seems to have discovered cancer, and a substantial portion of the smaller biotechnology companies are focused on it as well. Together, the companies are pouring billions of dollars into developing cancer drugs.

  • Analyst Says Lilly's A Loser Monday, 31 Aug 2009 | 8:55 AM ET

    After a long delay, Eli Lilly finally launched its new bloodthinner Effient just this month. But analysts are already buzzing about what's next.

  • Chadwick: Rationing Health Care is Scary Thursday, 27 Aug 2009 | 1:50 PM ET

    Reading Betsy McCaughey’s op-ed article in today’s Wall Street Journal, I understand fully why the elderly are so scared about the possibility of a nationalized health care system.

  • Glaxo Comes To The Defense Of Its alli Wednesday, 26 Aug 2009 | 9:52 AM ET

    British drugmaker GlaxoSmithKline is trying to keep from having to tighten its belt over new safety concerns with its weightloss pill, alli

  • Real Choice? It's Off Limits in Most Health-Care Bills Wednesday, 26 Aug 2009 | 8:22 AM ET
    doctor

    Real choice is not part of the bills moving through the Democratic-led Congress; even if the much-debated government-run insurance plan was created, it would not be available to most people who already have coverage.

  • Novartis Attackers Hold Ashes Hostage Tuesday, 25 Aug 2009 | 10:02 AM ET
    Graveyard that contains the family graves of Daniel Vasella, CEO/Chairman of Novartis.

    Am I missing something? Or is this not the way to go about advancing your cause?

  • Senator Moves to Block Medical Ghostwriting Wednesday, 19 Aug 2009 | 12:27 PM ET
    Senator Charles Grassley

    A growing body of evidence suggests that doctors at some of the nation’s top medical schools have been attaching their names and lending their reputations to scientific papers that were drafted by ghostwriters working for drug companies - articles that were carefully calibrated to help the manufacturers sell more products.

  • Diabetes Case Shows Pitfalls of Treatment Rules Tuesday, 18 Aug 2009 | 11:32 AM ET
    Diabetes

    It sounds like a simple idea for improving health care: draw up guidelines on how best to treat a particular illness and then pay doctors to follow them. That strategy, which some insurers and health plans already employ, has been embraced during the health care debate by some lawmakers in Congress who want to extend it more broadly.

  • On Gaining Access To Drugs & To Pfizer's CEO Friday, 14 Aug 2009 | 10:00 AM ET
    Pfizer

    Before I go on vacation for a week I wanted to close the loop and offer some random thoughts on a few things.

  • The FDAA: Food Drug & Accounting Administration Thursday, 13 Aug 2009 | 12:18 PM ET
    FDA

    Amid the ongoing healthcare reform brouhaha, pharma stocks are getting buffeted.

  • Regis Rages Against Pfizer Wednesday, 12 Aug 2009 | 12:47 PM ET
    USC football

    OK. I have to put aside the fact that he went to Notre Dame and is a diehard Fighting Irish fan (Go 'SC!), but Regis' trademark rant against Pfizer on "Fast Money" yesterday is too good not to blog it.